Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botox for hormonal female hair loss
IRCT20221016056203N1Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Nov 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of botulinum toxin type A in androgenetic alopecia (AGA), sponsored by Tehran University of Medical Sciences. Started Nov 2022; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on IRCT20221016056203N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20221016056203N1.